A detailed history of Elkhorn Partners Limited Partnership transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Elkhorn Partners Limited Partnership holds 1,000 shares of CRSP stock, worth $51,620. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,000
Holding current value
$51,620
% of portfolio
0.04%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$51.17 - $68.18 $51,170 - $68,180
1,000 New
1,000 $54,000
Q3 2023

Nov 13, 2023

BUY
$45.39 - $59.0 $9,985 - $12,980
220 Added 733.33%
250 $11,000
Q2 2023

Aug 14, 2023

SELL
$43.47 - $67.77 $24,777 - $38,628
-570 Reduced 95.0%
30 $2,000
Q1 2023

May 12, 2023

SELL
$41.0 - $56.12 $30,750 - $42,090
-750 Reduced 55.56%
600 $27,000
Q4 2022

Feb 14, 2023

BUY
$39.19 - $65.67 $52,906 - $88,654
1,350 New
1,350 $55,000
Q2 2022

Aug 12, 2022

SELL
$43.23 - $73.83 $23,776 - $40,606
-550 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$53.19 - $79.24 $10,638 - $15,847
200 Added 57.14%
550 $35,000
Q4 2021

Feb 14, 2022

BUY
$70.09 - $111.29 $15,770 - $25,040
225 Added 180.0%
350 $27,000
Q2 2021

Aug 13, 2021

BUY
$100.84 - $161.89 $12,605 - $20,236
125 New
125 $20,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.03B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Elkhorn Partners Limited Partnership Portfolio

Follow Elkhorn Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elkhorn Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Elkhorn Partners Limited Partnership with notifications on news.